{"id":"W2107216509","doi":"10.1136/annrheumdis-2012-202865","title":"Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; GlaxoSmithKline","keywords":"Belimumab; Medicine; Placebo; Internal medicine; Quality of life (healthcare); Randomized controlled trial; Systemic lupus erythematosus; Adverse effect; Physical therapy; B-cell activating factor; Immunology; Antibody; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00750755,0.001551729,0.003664142,0.000602128,0.000533005,0.001108517,0.0007783552,0.001758379,0.004845478],"category_scores_gemma":[0.00394196,0.0006964052,0.003513805,0.0005834823,0.001054509,0.0008571657,0.0006875379,0.002291408,0.000418568],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008525877,"about_ca_system_score_gemma":0.001043221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009810145,"about_ca_topic_score_gemma":0.003341924,"domain_scores_codex":[0.9967455,0.002160449,0.0004234881,0.000218144,0.0002332002,0.0002192163],"domain_scores_gemma":[0.9979278,0.000650971,0.0008094411,0.00009760776,0.0001601731,0.0003540769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9681746,0.001396389,0.001285361,0.004075607,0.003542139,0.00003642782,0.00006146425,0.0002297438,0.001902422,0.00006941881,0.0008937739,0.01833279],"study_design_scores_gemma":[0.9515862,0.03883133,0.005570651,0.0002899729,0.002002385,0.00006140884,0.00002678088,0.0001093618,0.0003406857,0.00007192695,0.001093838,0.00001551179],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8846095,0.1025924,0.0007859407,0.002202164,0.001007026,0.00367568,0.001959741,0.0001111105,0.00305657],"genre_scores_gemma":[0.9673089,0.0226546,0.001377673,0.001259892,0.0007308564,0.003213037,0.001762272,0.00001527728,0.001677615],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00750755,"threshold_uncertainty_score":0.0397042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0410180639309466,"score_gpt":0.313622220978431,"score_spread":0.2726041570474844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}